EURIDICE NOBRE: Open Payments
NPI 1952170367 · NORTH KINGSTOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 25 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $136 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $242 |
| ABBVIE INC. | 12 | $183 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: REXULTI, VRAYLAR, UZEDY, Auvelity.
Industry payments across RI — which companies pay providers there.
